19:00 Registration and walking dinner
SCIENTIFIC PROGRAMME
ASTELLAS Satellite Symposium
The many faces of mCRPC
Chair: Prof. L. Hoekx, UZ Antwerpen
20:00 The evolution of the classi_ cation of Gleason score as determined groups that would reflect better prognoses prostate cancer aggressiveness
Dr. Veronique Lindner, Hôpitaux Universitaires de Strasbourg, France
20:45 New data for the first line treatment of mCRPC after failing ADT
Prof. Brieuc Sautois, CHU de Liège
21:00 Break
BRISTOL-MYERS SQUIBB Satellite Symposium :
Immunotherapy: a new option to treat cancer
Chair: Prof. Sylvie Rottey, UZ Gent
21:15 Cancer and the Immune System
Prof. Pierre Coulie, Institut de Duve
21:45 Specifics of Cancer Immunotherapy in Daily Clinical Practice
Dr. Pascal Wolter, CHR Verviers
22:15 Closing by Chairs
22:30 Drinks